In the Boardroom - Boardroom, Financial

Filter

Current filters:

BoardroomFinancial

Popular Filters

Agilis Biotherapeutics and Intrexon collaborate on rare genetic disease

01-01-2014

US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel…

Agilis BiotherapeuticsBiotechnologyBoardroomFinancialIntrexonManagementRare diseasesResearch

Forest Labs names new CEO to replace Howard Solomon

11-09-2013

US drugmaker Forest Laboratories (NYSE: FRX) saw its shares rise 2.5% to $44.50 yesterday (September…

BoardroomFinancialForest LaboratoriesNorth AmericaPharmaceutical

Back to top